AI‐assisted warfarin dose optimisation with CURATE.AI for clinical impact: Retrospective data analysis

AI‐assisted warfarin dose optimisation with CURATE.AI for clinical impact: Retrospective data analysis

Abstract Background Standard‐of‐care for warfarin dose titration is conventionally based on physician‐guided drug dosing. This may lead to frequent deviations from target international normalized ratio (INR) due to inter‐ and intra‐patient variability and may potentially result in adverse events inc...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tiffany Rui Xuan Gan, Lester W. J. Tan, Mathias Egermark, Anh T. L. Truong, Kirthika Kumar, Shi‐Bei Tan, Sarah Tang, Agata Blasiak, Boon Cher Goh, Kee Yuan Ngiam, Dean Ho
Format:	Article
Language:	English
Published:	Wiley 2025-05-01
Series:	Bioengineering & Translational Medicine
Subjects:	artificial intelligence blood coagulation clinical decision support systems precision medicine warfarin
Online Access:	https://doi.org/10.1002/btm2.10757
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Personalized dose selection platform for patients with solid tumors in the PRECISE CURATE.AI feasibility trial
by: Agata Blasiak, et al.
Published: (2025-02-01)

Diagnosis of Impairments in the Hemostatic System in the Use of Warfarin in Cardiac Surgical Patients
by: E. I. Goncharova, et al.
Published: (2015-09-01)

EVALUATION OF SOME HEMATOLOGICAL PARAMETERS AND CLINICAL SIGNS AFTER REPEATED EXPOSURE TO WARFARIN IN DOGS
by: Israa Abdul Wadood Muhammad Ali
Published: (2016-06-01)

Characteristics of chronic subdural haematomas related to DOACs vs warfarin
by: Gokul Raj Krishna, et al.
Published: (2025-04-01)

Naoxintong Is Involved in the Coagulation Regulation of Warfarin Through the MAPK Pathway
by: Luo X, et al.
Published: (2025-01-01)

Risk of development of hemorrhagic complications due to warfarin therapy
by: O. I. Filippova, et al.
Published: (2017-12-01)

WARFARIN IN PATIENTS WITH CARDIOEMBOLIC STROKE
by: E. N. Dankovtseva, et al.
Published: (2015-12-01)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01)

Clinical Case: Atypical Warfarin-induced Skin Necrosis
by: T. V. Kondratieva, et al.
Published: (2019-11-01)

Frequencies of polymorphisms in genes affecting the pharmacokinetics of warfarin in the Zaporizhzhia region
by: M. Yu. Kolesnik, et al.
Published: (2021-07-01)

The impact of anti-infective therapy on patients undergoing warfarin treatment
by: Linlin Fu, et al.
Published: (2024-12-01)

Warfarin without Therapeutic Monitoring Is a Rodenticide, but This Time It Kills the Patient: A Warfarin Toxicity Case Report
by: Hossein Karballaei Mirzahosseini, et al.
Published: (2024-11-01)

ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: Yu. B. Belousov, et al.
Published: (2016-01-01)

SYNTHESIS, PHYSICO-CHEMICAL ANALYSIS AND PHARMACOLOGICAL ACTIVITY OF SOME DERIVATIVES OF WARFARIN
by: A. Z. Abyshev, et al.
Published: (2019-01-01)

Factors affecting target INR levels in homebound and ambulatory patients who use warfarin
by: Ozge Tuncer, et al.
Published: (2024-11-01)

Modern warfarin- dosing algorithms in patients with atrial fibrillation
by: M. Yu. Kolesnyk, et al.
Published: (2015-12-01)

Nontraumatic warfarin-related intrapulmonary hemorrhage presenting as a lung mass
by: Hiroyuki Tsuchida, et al.
Published: (2020-04-01)

SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS
by: E. S. Kropacheva
Published: (2016-01-01)

Warfarin-ciprofloxacin interaction complicated by subcapsular renal hematoma and retroperitoneal hematoma: Case report
by: Masoud Basheer Alshammari, et al.
Published: (2025-01-01)

THE INVASIVE DENTAL PROCEDURES IN PATIENTS TREATING WITH WARFARIN: POSSIBILITIES AND PROSPECTS FOR SAFETY
by: T. V. Kozlova, et al.
Published: (2016-01-01)

Severe Airway Obstruction due to Massive Retropharyngeal Hematoma in a Warfarin-Taking Patient with a Normal International Normalized Ratio
by: Hyun Young Cho, et al.
Published: (2021-03-01)

A surgical case of anti-coagulant ileus mimicking small-bowel tumors: a case report
by: Hideyuki Masui, et al.
Published: (2024-01-01)

Alternative therapy interaction with warfarin: what doctors should know
by: T. B. Kozlova, et al.
Published: (2010-06-01)

Mesoporous Silica Administration as a New Strategy in the Management of Warfarin Toxicity: An In-Vitro and In-Vivo Study
by: Fatemeh Farjadian, et al.
Published: (2024-12-01)

Revealing the mechanisms of warfarin-induced vascular calcification through metabolomics and network toxicology
by: Zhijiao Zhang, et al.
Published: (2025-06-01)

ADVANTAGES AND DISADVANTAGES OF WARFARIN AND PRADAXA THERAPY FOR VENOUS THROMBOEMBOLISM
by: B. S. Sukovatykh, et al.
Published: (2018-01-01)

WARFARIN: PLACE IN THE ANTICOAGULANT THERAPY TODAY
by: N. A. Novikova, et al.
Published: (2016-07-01)

SAFETY OF LONG-TERM THERAPY WITH WARFARIN: HEMORRHAGE FREQUENCY AND CLINICAL PREDICTORS (results of a prospective 15-year follow-up)
by: E. S. Kropacheva, et al.
Published: (2017-05-01)

Study of target INR achievement, incidence of hemorrhagic complications and affecting factors after during warfarin treatment in western area of China
by: Rui Shi, et al.
Published: (2025-05-01)

A Case of Gastrointestinal Hemorrage Due to Warfarin Interaction with Nalidixic Acid Resulting in Massive Blood Loss
by: D. A. Sychev, et al.
Published: (2020-05-01)

ANALYSIS OF STRUCTURAL FEATURES OF THE KETO-KETAL ISOMERS OF WARFARIN BY SPECTRAL METHODS
by: A. Z. Abyshev, et al.
Published: (2019-01-01)

Determining the effect of drug "Warfarin sodium" on toxicity indicators in an acute experiment
by: D.O. Hlavachek, et al.
Published: (2023-09-01)

The Value of Using Bedside Point of Care Testing for International Normalized Ratio in Patients on Warfarin Undergoing Dental Procedures and Bleeding Assessment; A Single Center Prospective Study
by: Albarkheel A, et al.
Published: (2025-07-01)

TIME IN THERAPEUTIC RANGE (TTR) IN ATRIAL FIBRILLATION WITH WARFARIN THERAPY IN SEMARANG, INDONESIA
by: Della Dafina Sekarsari, et al.
Published: (2021-10-01)

Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report)
by: N. T. Vatutin, et al.
Published: (2020-03-01)

Meta-analysis comparing apixaban versus warfarin anticoagulation therapies for patients with severe renal insufficiency
by: LIANG Qiao-jing, et al.
Published: (2019-01-01)

Efficacy and safety of apixaban and warfarin in prevention of ischemic stroke: a systematic review and meta-analysis
by: Wei Gu, et al.
Published: (2022-04-01)

Warfarin kullanımına bağlı gelişen subakut retroperitoneal kanamaya bağlı sol femoral sinir nöropatisi
by: Leyla Karaca, et al.
Published: (2013-01-01)

CLINICAL FACTORS AND ANTICOAGULATION LEVEL THAT DETERMINE THE SUDDEN LOSS OF KIDNEY FUNCTION IN PATIENTS LONG-TAKING WARFARIN (A 5-YEAR PROSPECTIVE, OBSERVATIONAL STUDY)
by: E. S. Kropacheva, et al.
Published: (2018-05-01)

CYP2C9*2 and CYP2C9*3 allele variants of CYP2C9 cytochrome gene in St. Petersburg population, and their clinical role in warfarin anticoagulant therapy
by: O. V. Sirotkina, et al.
Published: (2004-12-01)